Investors aren’t backing fertility startups like they used to — part of digital health’s reset

(This sto­ry is from our new Health Tech newslet­ter. If you’d like to sign up, just click here.)  

Fund­ing for star­tups that sell re­pro­duc­tive and ma­ter­nal health ser­vices to em­ploy­ers slumped af­ter a pan­dem­ic-era spike.

The to­tal fund­ing for these star­tups fell to $54 mil­lion in 2023 com­pared to $65.5 mil­lion in 2019, ac­cord­ing to da­ta ob­tained by End­points News from Rock Health. The re­search and ven­ture firm tracks com­pa­nies that have raised at least $2 mil­lion in ven­ture cap­i­tal and meet its de­f­i­n­i­tion of dig­i­tal health, or com­pa­nies that build and sell tech, in­clud­ing com­pa­nies that are paired with a ser­vice as long as tech is part of that ser­vice.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.